| First Author | Mattan NS | Year | 2010 |
| Journal | Neurobiol Dis | Volume | 40 |
| Issue | 2 | Pages | 432-43 |
| PubMed ID | 20637282 | Mgi Jnum | J:165983 |
| Mgi Id | MGI:4839411 | Doi | 10.1016/j.nbd.2010.07.003 |
| Citation | Mattan NS, et al. (2010) Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. Neurobiol Dis 40(2):432-43 |
| abstractText | Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPA-deficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination. |
